A CEO's primary role differs fundamentally based on company type. In an asset-centric biotech, the CEO must act as a hands-on program manager, micromanaging execution. In a platform company, the CEO must be deeply embedded in the science to predict and leverage the technology's long-term trajectory.

To humanize R&D and maintain motivation, biotech leaders bring patients into the company. This practice directly connects scientists with the human impact of their work, grounding the entire team in their shared purpose, especially on difficult days.

The transition from a leadership role at a large pharma company like Gilead to a biotech CEO involves a massive shift in scope. Instead of managing one large function with a large team, a biotech CEO is hands-on with every aspect of the company, from science to finance.

Kevin Pojasek credits his effectiveness to a deliberate 12-year journey through diverse roles—investing, company creation, research, and clinical operations. This broad experience allows a leader to understand how all parts of the company, from high-level strategy to detailed science, fit together.

Successful biotech leadership requires a clear decision-making hierarchy. Dr. Bahija Jallal advocates for a framework where patient welfare is paramount, followed by scientific rigor. Financial success is treated as a byproduct of excelling in the first two areas, not the primary goal.

In a crowded market, a leader who lives and breathes the business, acting as a charismatic ambassador, can be the deciding factor in its success. Visionary leadership that inspires the team and the market is crucial. A technically superior product can fail under a flat, uninspiring leader.

To bridge the psychological gap between direct patient care and the abstract world of pharma R&D, a former clinician visualizes data points not as numbers, but as the real people he once treated. This mental model keeps the patient as the 'North Star' in all decisions.

A crucial piece of advice for biotech founders is to interact with patients as early as possible. This 'patient first' approach helps uncover unmet needs in their treatment journey, providing a more powerful and differentiated perspective than focusing solely on the scientific or commercial landscape.

The most critical role for a physician co-founder extends beyond the initial idea. They must act as the primary evangelist and validator, sharing the engineering progress with their peers to ensure the device's design and function align with the broader clinical community's needs and vision.